In this episode, Dr. Ahmad Al-Hassiny interviews Amir Mansouri, CEO and co-founder of SprintRay, about the company's recent acquisition of EnvisionTEC's assets following its bankruptcy under Desktop Health.

The discussion covers the strategic rationale behind the acquisition, immediate plans for supporting stranded EnvisionTEC customers, and SprintRay's entry into the dental laboratory market. Mansouri explains how the asset purchase includes patents, IP, and customer lists while avoiding liabilities.

The conversation explores the differences between chairside and laboratory markets, cross-platform resin compatibility plans, and the future of both brands within the dental 3D printing industry.

00:00:00 - Introduction

00:00:45 - The EnvisionTEC Story

00:04:16 - Acquisition Details

00:07:40 - Customer Support Plans

00:09:23 - Cross-Platform Compatibility

00:13:13 - Lab Market Strategy

00:17:53 - Brand Future

00:21:08 - Industry Consolidation

00:24:48 - What's Next

00:28:53 - Closing